Rice Derivative Market Growth Opportunities & Competitive Landscape, 2026–2035

The genomics
market was valued at USD 44.7 billion in 2025 and is projected to grow at a
15.6% CAGR from 2026 to 2035. Falling sequencing costs, increasing clinical
adoption, biomarker-led drug development, population-health programs, and the
rise of precision medicine are accelerating market expansion.

Genomic analysis is moving beyond specialist research into
clinical diagnostics, oncology profiling, rare-disease testing,
pharmacogenomics, and public-health infrastructure. Demand is increasing for
sequencing platforms, sample preparation, consumables, bioinformatics,
interpretation, data security, and clinically validated reporting workflows.

Get more information @ https://www.gminsights.com/industry-analysis/genomics-market

Products generated USD 29.89 billion in revenue in 2025.
Instruments, consumables, and reagents remain core market components, with
recurring consumable use becoming increasingly important after platform
installation.

Sequencing accounted for USD 16.97 billion in market value
in 2025. Its use in broad genomic-variation analysis, precision medicine,
clinical research, rare-disease testing, and drug discovery supports its
position as the largest technology segment.

North America generated USD 19.07 billion in revenue in
2025, representing 42.7% of the global market. Pharmaceutical demand, federal
research infrastructure, clinical testing channels, and recurring reagent and
service requirements support regional leadership.

Illumina led the market with over 49.5% share in 2025. Its
sequencing-platform portfolio, strong consumables revenue base, DRAGEN analysis
solutions, and connected informatics capabilities reinforce its market
position.

Some of the major players in this market are Thermo Fisher
Scientific, Agilent Technologies, BGI Genomics, F. Hoffmann-La Roche, Bio-Rad
Laboratories, Color Genomics, Danaher, Eppendorf, Eurofins Scientific, Myriad
Genetics, NVIDIA, Oxford Nanopore Technologies, Pacific Biosciences of
California, QIAGEN, and Quest Diagnostics.

Table of Contents

Chapter 1. Methodology and Scope

1.1 Market scope and definition

1.2 Research design

1.2.1 Research approach

1.2.2 Data collection methods

1.3 Data mining sources

1.3.1 Global

1.3.2 Regional/Country

1.4 Base estimates and calculations

1.4.1 Base year calculation

1.4.2 Key trends for market estimation

1.5 Primary research and validation

1.5.1 Primary sources

1.6 Forecast model

1.7 Research assumptions and limitations

Chapter 2. Executive Summary

2.1 Industry 360° synopsis

2.2 Key market trends

2.2.1 Regional

2.2.2 Type

2.2.3 Technology

2.2.4 Application

2.2.5 End use

2.3 TAM analysis, 2025-2035

2.4 CXO perspectives: Strategic imperatives

2.4.1 Executive decision points

2.4.2 Critical success factors

2.5 Future outlook and strategic recommendations

Chapter 3. Industry Insights

3.1 Industry ecosystem analysis

3.1.1 Sequencing-platform suppliers

3.1.2 Reagent and consumable providers

3.1.3 Sample-preparation and automation suppliers

3.1.4 Bioinformatics and computing providers

3.1.5 Clinical laboratories and testing services

3.1.6 Pharmaceutical and biotechnology companies

3.1.7 Hospitals, research institutes, and public-health programs

3.1.8 Profit margin analysis

3.1.9 Value addition at each stage

3.1.10 Factors affecting the value chain

3.2 Industry impact forces

3.2.1 Growth drivers

3.2.1.1 Rising prevalence of genetic and chronic diseases

3.2.1.2 Advancements in DNA sequencing and gene-editing technologies

3.2.1.3 Increasing adoption of precision medicine

3.2.1.4 Government initiatives and funding for genomics research

3.2.2 Industry pitfalls and challenges

3.2.2.1 Ethical and privacy concerns around genetic data

3.2.2.2 High cost and affordability issues

3.2.2.3 Data interpretation, reimbursement, and workforce gaps

3.2.3 Market opportunities

3.2.3.1 Clinical genomics and precision diagnostics

3.2.3.2 Biomarker-led drug discovery and development

3.2.3.3 Population genomics and national data programs

3.3 Growth potential analysis

3.4 Technology and innovation landscape

3.4.1 Next-generation sequencing

3.4.2 Long-read sequencing

3.4.3 PCR and digital PCR

3.4.4 Microarray and cytogenomics

3.4.5 Bioinformatics, AI, and multiomic analysis

3.5 Pricing analysis

3.5.1 Historical price trend analysis

3.5.2 Sequencing, reagent, and service-cost dynamics

3.5.3 Pricing strategy by technology and workflow

3.6 Regulatory landscape

3.6.1 Clinical laboratory and diagnostic requirements

3.6.2 Genetic-data privacy and consent requirements

3.6.3 Data-sharing and cross-border governance standards

3.7 Porter’s analysis

3.8 PESTEL analysis

3.9 Impact of AI and generative AI on the market

3.9.1 AI-driven disruption of existing business models

3.9.2 GenAI use cases and adoption roadmap by segment

3.9.3 Risks, limitations, and regulatory considerations

About Global Market Insights Inc.

Global Market Insights Inc., headquartered in Delaware, U.S., is a global
market research and consulting service provider, offering syndicated and custom
research reports along with growth consulting services. Our business
intelligence and industry research reports offer clients with penetrative
insights and actionable market data specially designed and presented to aid
strategic decision making. These exhaustive reports are designed via a
proprietary research methodology and are available for key industries such as
chemicals, advanced materials, technology, renewable energy, and biotechnology.

Contact Us:

Aashit Tiwari

Corporate Sales, USA

Global Market Insights Inc.

Toll Free: 1-888-689-0688

USA: +1-302-846-7766

Europe: +44-742-750-8484

APAC: +65-3129-7718

Email: sales@gminsights.com